Health & research

Snus and COVID-19 – the Research Question from 2020

  • 2020-05-28
  • Author: daniel west
  • Updated: 2026-10-21
  • 4 min read
  • Popular(989)
Snus and COVID-19 – the Research Question from 2020

Historical background to a research question from spring 2020. Researchers then investigated whether nicotine could affect the risk of becoming ill or seriously ill with COVID-19. Later Swedish studies did not support the hypothesis that nicotine in tobacco is protective. Smoking, snus and nicotine should not be used as protection against or treatment for COVID-19.

What did the French report show?

An early report from the Pitié-Salpêtrière Hospital in Paris included 482 patients with COVID-19: 343 inpatients and 139 outpatients. Among the inpatients, 4.4 percent reported smoking daily. The corresponding proportion among outpatients was 5.3 percent.

The report compared the patients’ smoking habits with French population data from 2018, in which 25.4 percent were daily smokers. The researchers took age and sex into account in the comparison. The low proportion of smokers raised a research question, but did not show that smoking reduced the risk of severe illness.

What did the hypothesis about nicotine and receptors entail?

In April 2020, researchers proposed that nicotine’s binding to nicotinic acetylcholine receptors could be significant for the interaction between the virus and the body’s cells. The hypothesis did not show that nicotine prevented the virus from entering cells or reproducing.

What did the researchers in England investigate?

During May 2020, early analyses of the association between smoking and COVID-related death in England were published. These included OpenSAFELY, whose expanded study was published in July of the same year.

In the published study, the association with smoking varied depending on which factors the analysis took into account. A fully adjusted analysis produced a lower estimated risk of death for people who smoked. But it also included diseases that smoking can cause, which made the interpretation more difficult. The authors did not conclude that nicotine protected against COVID-19. Nor did the study provide grounds for recommending smoking to prevent serious complications.

Why did Swedish researchers want to study snus?

By studying snus, the researchers could investigate nicotine use without exposure to tobacco smoke. In an interview with Dagens Nyheter in May 2020, Cecilia Magnusson, then an adjunct professor and head of the Centre for Epidemiology and Community Medicine, described the question of whether snus could be associated with the risk of severe COVID-19.

A possible effect of nicotine and its potential significance for future treatment was a research idea. An association between snus use and illness would not in itself have proved that nicotine was the cause. More research was required.

What did the later Swedish studies show?

In January 2023, a Swedish study of 424,386 residents of Stockholm was published, using data on tobacco use from dental records and registered COVID outcomes during 2020. Cecilia Magnusson was one of the co-authors. The results did not support the hypothesis that nicotine in tobacco protected against COVID-19. The researchers observed an unexplained association between smoking and fewer registered cases, but no corresponding protective association for snus.

A follow-up published in November 2023 included 418,975 people and covered the period from October 2020 to June 2021. Snus use was associated with more registered COVID diagnoses. Nor did this study support the nicotine protection hypothesis.

Both were observational studies. An association with a registered diagnosis is not the same as a proven effect on the risk of infection or the risk of becoming seriously ill.

Is nicotine or tobacco protection against COVID-19?

Smoking, snus and nicotine are not established ways of preventing or treating COVID-19. WHO warned as early as May 2020 about unsubstantiated claims of protection and also stated in 2022 that the evidence supporting nicotine as prevention or treatment was insufficient.

Smoking is harmful to health and can worsen outcomes in COVID-19. Nicotine is a highly addictive substance.

Quick Facts

Reading Time
4 min
Popularity
Popular
Category
Health & research
Published
2020-05-28